Purple Biotech PPBT
NASDAQ PPBT
$1.15 +0.06 (+5.99%)
At close: Oct 21, 2026 · 4:00 PM EDT

Purple Biotech (PPBT) Debt Ratio (2014 - 2016)

Updated

Purple Biotech's Debt Ratio came in at 0.01 for Q4 2016.

Analysis

Purple Biotech (PPBT) Debt Ratio (2014 - 2016) Analysis & Trends

  • Going back by year, Debt Ratio was 0.17 in FY2014.
  • The Q4 2016 figure represents the highest quarterly Debt Ratio since Q4 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 0.39
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 0.24
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 0.52
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 0.42
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 0.08
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 0.28
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 0.60
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 0.53
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 0.31
10 Purple Biotech 537,659.78 -32.02 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 0.01
Dec 31, 2014 0.17
API Access

Purple Biotech Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=PPBT&period=max&api_key=YOUR_API_KEY